{"id":3698,"date":"2021-06-03T05:44:00","date_gmt":"2021-06-03T05:44:00","guid":{"rendered":"https:\/\/egeajans.ege.edu.tr\/?p=3698"},"modified":"2021-06-03T07:45:14","modified_gmt":"2021-06-03T07:45:14","slug":"prof-dr-yuceyar-bugun-ms-tedavisi-olan-bir-hastaliktir","status":"publish","type":"post","link":"https:\/\/egeajans.ege.edu.tr\/index.php\/2021\/06\/03\/prof-dr-yuceyar-bugun-ms-tedavisi-olan-bir-hastaliktir\/","title":{"rendered":"Prof. Dr. Y\u00fcceyar, \u201cBug\u00fcn, MS tedavisi olan bir hastal\u0131kt\u0131r\u201d"},"content":{"rendered":"<p style=\"text-align: justify;\">\u00a0\u201cD\u00fcnya Multipl Skleroz (MS) G\u00fcn\u00fc\u201d<\/p>\n<p style=\"text-align: justify;\"><b>Prof. Dr. Y\u00fcceyar, \u201cBug\u00fcn, MS tedavisi olan bir hastal\u0131kt\u0131r\u201d<\/b><\/p>\n<p style=\"text-align: justify;\">D\u00fcnya MS G\u00fcn\u00fc dolay\u0131s\u0131yla Multipl Skleroz hastal\u0131\u011f\u0131 ile ilgili a\u00e7\u0131klama yapan Ege \u00dcniversitesi T\u0131p Fak\u00fcltesi N\u00f6roloji Anabilim Dal\u0131 \u00d6\u011fretim \u00dcyesi Prof. Dr. Ay\u015fe Nur Y\u00fcceyar, \u201cD\u00fcnya\u2019da ve \u00fclkemizde MS\u2019in erken tan\u0131s\u0131 ve etkin tedavisine y\u00f6nelik bilimsel geli\u015fmeler b\u00fcy\u00fck bir h\u0131zla devam ediyor. MS hastas\u0131, ya\u015fam\u0131n i\u00e7inde yer almal\u0131, i\u015f hayat\u0131na devam etmeli, hobilerini geli\u015ftirmeli, sosyal ya\u015famdan geri \u00e7ekilmemelidir\u201d dedi.<\/p>\n<p style=\"text-align: justify;\">Uluslararas\u0131 Multipl Skleroz(MS) Federasyonu ve D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc (WHO) taraf\u0131ndan her y\u0131l May\u0131s ay\u0131n\u0131n son \u00c7ar\u015famba g\u00fcn\u00fc \u201cD\u00fcnya MS G\u00fcn\u00fc\u201d olarak kutlan\u0131yor. D\u00fcnyada ve T\u00fcrkiye\u2019de pek \u00e7ok kurulu\u015f,<b>\u00a0<\/b>MS hastal\u0131\u011f\u0131n\u0131 kitlelere duyurmak ve fark\u0131ndal\u0131k yaratmak i\u00e7in hafta boyunca \u00e7e\u015fitli etkinlikler d\u00fczenliyor.\u00a0<b>\u00a0<\/b>Prof. Dr. Ay\u015fe Nur Y\u00fcceyar, \u201cMS, 20-40 ya\u015f aras\u0131nda ba\u015flayan ve kad\u0131nlarda 2-3 kat daha s\u0131k g\u00f6r\u00fclen,\u00a0 genellikle alevlenme ve d\u00fczelmelerle seyreden, santral sinir sistemini (beyin ve omurilik) etkileyen bir hastal\u0131kt\u0131r. Genel kabule g\u00f6re ba\u011f\u0131\u015f\u0131kl\u0131k sisteminin yanl\u0131\u015f \u00e7al\u0131\u015fmas\u0131 sonucu myelin adl\u0131 sinir h\u00fccresi k\u0131l\u0131flar\u0131nda, sinir lifi ve sinir h\u00fccrelerinde hasar olu\u015fturan bir mekanizmaya sahiptir\u201d diye konu\u015ftu.<b><\/b><\/p>\n<p style=\"text-align: justify;\"><b>\u201cMS, beyin ve omurili\u011fi etkiliyor\u201d<\/b><\/p>\n<p style=\"text-align: justify;\">MS\u2019in beyin ve omurili\u011fi etkiledi\u011fi i\u00e7in \u00e7ok \u00e7e\u015fitli n\u00f6rolojik belirtilere yol a\u00e7abildi\u011fini ifade eden Prof. Dr. Y\u00fcceyar, \u201cBir g\u00f6zde g\u00f6rme bulan\u0131kl\u0131\u011f\u0131, puslu g\u00f6rme, \u00e7ift g\u00f6rme, bir kolda bacakta ya da her iki bacakta g\u00fc\u00e7s\u00fczl\u00fck, y\u00fcr\u00fcmede dengesizlik, bir veya iki elde titreme, y\u00fczde kol ve bacaklarda uyu\u015fma, idrar ka\u00e7\u0131rma ya da yapamama gibi belirtilerle en \u00e7ok kendini g\u00f6stermektedir. MS; hastalar\u0131n \u00e7o\u011funda ataklar ve d\u00fczelmelerle, \u00e7ok daha az bir k\u0131sm\u0131nda ise s\u00fcrekli olarak ilerleyici belirtilerle seyretmektedir. Atak olarak kabul edilen belirtiler genellikle saatler i\u00e7inde ortaya \u00e7\u0131kan, 24 saatten uzun s\u00fcren, ate\u015fin ve enfeksiyonun e\u015flik etmedi\u011fi yeni n\u00f6rolojik belirtilerdir. Ataklar \u00f6zellikle hastal\u0131\u011f\u0131n ba\u015flang\u0131\u00e7 d\u00f6neminde tamamen d\u00fczelme g\u00f6sterse de ilerleyen y\u0131llarda baz\u0131 belirtilerin kal\u0131c\u0131 hale gelebilece\u011fi bilinmektedir. Yeni MS tan\u0131s\u0131 alm\u0131\u015f bir hastan\u0131n ge\u00e7mi\u015finde kendili\u011finden ge\u00e7en, bir kol ve baca\u011f\u0131nda uyu\u015fma, g\u00fc\u00e7 kayb\u0131, beceriksizlik veya bir g\u00f6z\u00fcnde bulan\u0131kl\u0131k gibi ba\u015fka nedenlere ba\u011flanm\u0131\u015f yak\u0131nmas\u0131 olabilir\u201d dedi.<\/p>\n<p style=\"text-align: justify;\">T\u00fcrkiye\u2019de 50 bin, d\u00fcnyada ise 2.5 milyondan fazla insan\u0131 etkileyen MS hastal\u0131\u011f\u0131n\u0131n neden ve nas\u0131l olu\u015ftu\u011funa ait bilgilere her ge\u00e7en g\u00fcn yeni bilimsel verilerle ula\u015f\u0131lmaya \u00e7al\u0131\u015f\u0131ld\u0131\u011f\u0131n\u0131 belirten Prof. Dr. Y\u00fcceyar, \u201cMS hastal\u0131\u011f\u0131n\u0131n temel nedeni v\u00fccudun ba\u011f\u0131\u015f\u0131kl\u0131k sisteminin kendi h\u00fccrelerine hedef \u015fa\u015f\u0131rarak sald\u0131rmas\u0131 ve sinir k\u0131l\u0131f\u0131, sinir h\u00fccrelerinde i\u015flevlerinin yapmas\u0131n\u0131n engellenmesidir. MS, kal\u0131tsal bir hastal\u0131k de\u011fildir, di\u011fer ba\u011f\u0131\u015f\u0131kl\u0131k sistemi hastal\u0131klar\u0131nda oldu\u011fu gibi bir genetik yatk\u0131nl\u0131ktan s\u00f6z edilebilir\u201d dedi.<\/p>\n<p style=\"text-align: justify;\"><b>\u201cMS hastal\u0131\u011f\u0131nda \u00e7evresel fakt\u00f6rler de etkili\u201d<\/b><\/p>\n<p style=\"text-align: justify;\">MS hastal\u0131\u011f\u0131nda \u00e7evresel fakt\u00f6rlerin etkisine de\u011finen Prof. Dr. Y\u00fcceyar, \u201cYap\u0131lan \u00e7al\u0131\u015fmalar sonucunda genetik yatk\u0131nl\u0131k d\u0131\u015f\u0131nda sigara i\u00e7me, baz\u0131 vir\u00fcslere maruz kalma, g\u00fcne\u015f \u0131\u015f\u0131\u011f\u0131na az maruziyet, D vitamini eksikli\u011fi ve ergenlik d\u00f6neminde obez veya a\u015f\u0131r\u0131 kilolu olma gibi \u00e7evresel fakt\u00f6rler MS geli\u015fim riski ile ili\u015fkilendirilmi\u015ftir\u201d dedi. MS hastal\u0131\u011f\u0131nda erken tan\u0131n\u0131n \u00f6nemli oldu\u011funu belirten ve tan\u0131da uygulanan testler hakk\u0131nda bilgi veren Prof. Dr. Y\u00fcceyar, \u201cMS hastal\u0131\u011f\u0131n\u0131n ilk atakta erken tan\u0131s\u0131 ve erken tedavisi hastal\u0131\u011f\u0131n kontrol alt\u0131na al\u0131nmas\u0131 ve ileride geli\u015febilecek \u00f6z\u00fcrl\u00fcl\u00fc\u011f\u00fcn engellenmesi nedeniyle \u00e7ok \u00f6nemlidir. MS bir\u00e7ok hastal\u0131\u011f\u0131 taklit edebilir ve bu nedenle ay\u0131r\u0131c\u0131 tan\u0131 bir\u00e7ok incelemeyi\u00a0 gerektirebilir. Tan\u0131da ve ay\u0131r\u0131c\u0131 tan\u0131da MRG (manyetik rezonans g\u00f6r\u00fcnt\u00fcleme) ve beyin omurilik s\u0131v\u0131s\u0131n\u0131n (BOS) incelenmesi vazge\u00e7ilmez yararl\u0131 y\u00f6ntemlerdir\u201d diye konu\u015ftu.<\/p>\n<p style=\"text-align: justify;\">MS konusunda d\u00fcnya ve \u00fclkemizdeki geli\u015fmelerden bahseden Prof. Dr. Y\u00fcceyar, \u201cD\u00fcnya\u2019da ve \u00fclkemizde MS\u2019in erken tan\u0131s\u0131 ve etkin tedavisine y\u00f6nelik bilimsel geli\u015fmeler b\u00fcy\u00fck bir h\u0131zla devam ediyor. 1990\u2019l\u0131 y\u0131llar \u00f6ncesinde MS\u2019de onayl\u0131 tek bir ila\u00e7 bulunmaz iken bug\u00fcn hastal\u0131k aktivitesine etkili, say\u0131s\u0131 15\u2019i bulan enjeksiyon tedavileri, a\u011f\u0131zdan haplar ve serum \u015feklinde ila\u00e7lar bulunmaktad\u0131r. Ancak hastal\u0131\u011f\u0131n aktivitesini durduracak tedaviler yan\u0131 s\u0131ra kal\u0131c\u0131 \u00f6z\u00fcrl\u00fc\u011f\u00fc geli\u015fmi\u015f hastalar\u0131m\u0131z\u0131n ya\u015fam kalitesini art\u0131rmak i\u00e7in semptomatik tedaviler ve ya\u015famlar\u0131n\u0131n bir par\u00e7as\u0131 olacak fiziksel egzersiz ve rehabilitasyonun \u00e7ok \u00f6nemli yakla\u015f\u0131mlar oldu\u011funu s\u00f6ylemek gerekir\u201d dedi.<b><\/b><\/p>\n<p style=\"text-align: justify;\"><b>\u201cMS hastal\u0131\u011f\u0131nda sosyal, ailesel ve toplumsal destek \u00e7ok \u00f6nemlidir\u201d<\/b><\/p>\n<p style=\"text-align: justify;\">MS hastal\u0131\u011f\u0131n\u0131n bula\u015f\u0131c\u0131 ve \u00f6ld\u00fcr\u00fcc\u00fc bir hastal\u0131k olmad\u0131\u011f\u0131n\u0131 belirten ve MS hastalar\u0131n\u0131n dikkat etmesi gereken noktalar hakk\u0131nda da bilgi veren Prof. Dr. Y\u00fcceyar,<b>\u00a0\u201c<\/b>MS hastas\u0131, hastal\u0131\u011f\u0131na umut dolu pencereden bakmal\u0131d\u0131r. Bug\u00fcn, MS \u00e7aresizlik ve \u00fcmitsizli\u011fe yol a\u00e7an, tedavisi olmayan bir hastal\u0131k olmaktan \u00e7\u0131km\u0131\u015ft\u0131r. MS hastal\u0131\u011f\u0131nda sosyal, ailesel ve toplumsal destek \u00e7ok \u00f6nemlidir. MS hastas\u0131, ya\u015fam\u0131n i\u00e7inde yer almal\u0131, i\u015f hayat\u0131na devam etmeli, hobilerini geli\u015ftirmeli, sosyal ya\u015famdan geri \u00e7ekilmemelidir. Tan\u0131 al\u0131r almaz sa\u011fl\u0131kl\u0131 ya\u015fam prensiplerini benimsemesi, MS\u2019in bireye getirece\u011fi en \u00f6nemli olumlu geli\u015fme olacakt\u0131r. MS\u2019li birey ve n\u00f6roloji uzman\u0131 aras\u0131nda s\u0131k\u0131 bir i\u015f birli\u011fi gerektiren bu hastal\u0131kta erken tedavi kadar tedavide kalmak, ilac\u0131 b\u0131rakmamak, ilaca uyum g\u00f6stermek, MS konusunda uzman hekimin d\u00fczenli kontrollerini aksatmamak \u00f6nemlidir. Uzun soluklu bir tedavinin ba\u015far\u0131s\u0131nda hasta, MS hekimi ve MS hem\u015fire \u00fc\u00e7geninin ileti\u015fimi \u00e7ok de\u011ferlidir\u201d\u00a0 dedi.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00a0\u201cD\u00fcnya Multipl Skleroz (MS) G\u00fcn\u00fc\u201d Prof. Dr. Y\u00fcceyar, \u201cBug\u00fcn, MS tedavisi olan bir hastal\u0131kt\u0131r\u201d D\u00fcnya MS G\u00fcn\u00fc dolay\u0131s\u0131yla Multipl Skleroz hastal\u0131\u011f\u0131 ile ilgili a\u00e7\u0131klama yapan Ege \u00dcniversitesi T\u0131p Fak\u00fcltesi N\u00f6roloji&hellip;<\/p>\n","protected":false},"author":2,"featured_media":3699,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-3698","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-gncl"],"_links":{"self":[{"href":"https:\/\/egeajans.ege.edu.tr\/index.php\/wp-json\/wp\/v2\/posts\/3698","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/egeajans.ege.edu.tr\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/egeajans.ege.edu.tr\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/egeajans.ege.edu.tr\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/egeajans.ege.edu.tr\/index.php\/wp-json\/wp\/v2\/comments?post=3698"}],"version-history":[{"count":1,"href":"https:\/\/egeajans.ege.edu.tr\/index.php\/wp-json\/wp\/v2\/posts\/3698\/revisions"}],"predecessor-version":[{"id":3700,"href":"https:\/\/egeajans.ege.edu.tr\/index.php\/wp-json\/wp\/v2\/posts\/3698\/revisions\/3700"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/egeajans.ege.edu.tr\/index.php\/wp-json\/wp\/v2\/media\/3699"}],"wp:attachment":[{"href":"https:\/\/egeajans.ege.edu.tr\/index.php\/wp-json\/wp\/v2\/media?parent=3698"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/egeajans.ege.edu.tr\/index.php\/wp-json\/wp\/v2\/categories?post=3698"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/egeajans.ege.edu.tr\/index.php\/wp-json\/wp\/v2\/tags?post=3698"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}